Solara Active Pharma Sciences Ltd
Solara Active Pharma Sciences Ltd (SOLARA) last traded at ₹627, a market capitalisation of ₹2,997 crore, on a P/E of 702. Over the past 52 weeks the stock has ranged between ₹422 and ₹712. Solara Active Pharma Sciences Ltd last reported results for the quarter ended Jun 2026, with sales of ₹382 crore and net profit of ₹16 crore. Solara Active Pharma Sciences Ltd’s annual general meeting is scheduled for 18 Sept 2026. Figures are as of 25 Aug 2026 and are not real time.
Solara Active Pharma Sciences Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Solara Active Pharma Sciences Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹382 cr, up 19.7% from ₹319 cr a year earlier. Net profit was ₹16 cr, up 45.5% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 347 | 300 | 273 | 319 | 314 | 349 | 387 | 382 |
| Expenses | 286 | 243 | 228 | 262 | 279 | 312 | 330 | 320 |
| Operating profit | 61 | 58 | 45 | 57 | 35 | 37 | 58 | 62 |
| OPM % | 18% | 19% | 17% | 18% | 11% | 11% | 15% | 16% |
| Other income | 0 | 1 | 6 | 1 | 0 | -7 | 6 | 3 |
| Interest | 28 | 27 | 29 | 24 | 21 | 22 | 28 | 22 |
| Depreciation | 25 | 25 | 24 | 24 | 24 | 26 | 26 | 27 |
| Profit before tax | 8 | 8 | -2 | 11 | -10 | -17 | 10 | 16 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net profit | 8 | 8 | -2 | 11 | -10 | -17 | 10 | 16 |
| EPS (₹) | 2.22 | 2.24 | -0.58 | 2.91 | -2.79 | -4.82 | 2.65 | 3.41 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Solara Active Pharma Sciences Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 1,617 | 1,268 | 1,444 | 1,289 | 1,284 | 1,369 | 1,431 |
| Operating profit | 386 | 81 | 134 | -95 | 206 | 187 | 192 |
| OPM % | 24% | 6% | 9% | -7% | 16% | 14% | 13% |
| Net profit | 221 | -58 | -22 | -567 | 1 | -7 | -2 |
| EPS (₹) | 46.22 | -12.11 | -4.62 | -118.21 | 0.15 | -2.05 | -1.55 |
TTM is the trailing twelve months to the most recent quarter.
Solara Active Pharma Sciences Ltd growth and returns
- 10 Years
- %
- 5 Years
- -3%
- 3 Years
- -2%
- TTM
- 15%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 25%
- TTM
- -83%
- 10 Years
- %
- 5 Years
- -16%
- 3 Years
- 23%
- 1 Year
- 0%
- 10 Years
- %
- 5 Years
- -7%
- 3 Years
- -12%
- Last Year
- 0%
Solara Active Pharma Sciences Ltd shareholding pattern
Promoters held 41.93% at Jun 2026, broadly unchanged since Jun 2025. FIIs 11.52% and DIIs 3.74%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 37.27% | 37.23% | 37.94% | 42.01% | 42.01% | 42.00% | 42.00% | 41.93% |
| FIIs | 14.25% | 14.67% | 14.63% | 14.25% | 13.58% | 11.98% | 11.59% | 11.52% |
| DIIs | 3.37% | 3.19% | 2.61% | 2.62% | 2.69% | 3.64% | 3.75% | 3.74% |
| Public | 45.11% | 44.92% | 44.82% | 41.10% | 41.71% | 42.37% | 42.66% | 42.79% |
| No. of shareholders | 71,882 | 83,148 | 75,791 | 74,334 | 72,479 | 71,890 | 70,400 | 70,490 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
When is Solara Active Pharma Sciences Ltd’s AGM?
Solara Active Pharma Sciences Ltd’s annual general meeting is scheduled for 18 Sept 2026.
- AGMNinth Annual General Meeting (AGM) to be held through VC/OAVM
See the full results calendar for every Indian company reporting in the next 30 days.
Solara Active Pharma Sciences Ltd corporate filings
- Solara Active Pharma Sciences Limited has informed the stock exchange regarding the Newspaper publication with respect to the Ninth Annual General Meeting.Company Updatelow impact
Cruxal's analysis: Solara Active Pharma Sciences Limited has fulfilled regulatory requirements under…
Read the full analysis - Conversion of Partly paid-up Rights Equity Shares into fully paid-up Equity shares in relation to the rights issue by the Company, upon receipt of Call Monies, as applicable.Company Updatelow impact
Cruxal's analysis: Solara Active Pharma Sciences Limited has approved the conversion of 2,79,582 partly…
Read the full analysis - Solara Active Pharma Sciences Limited has informed the Exchange regarding allotment of 2250 equity shares pursuant to exercise of ESOP optionsCompany Updatelow impact
Cruxal's analysis: Solara Active Pharma Sciences Limited has announced the allotment of 2,250 equity shares…
Read the full analysis - Solara Active Pharma Sciences Limited has informed the exchange regarding the update with respect to our intimation dated July 23, 2026, regarding appointment of Chief Information Officer ....Company Updatelow impact
Cruxal's analysis: Solara Active Pharma Sciences Limited has issued a routine disclosure regarding a change…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Solara Active Pharma Sciences Ltd
Cruxal reads every Solara Active Pharma Sciences Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.